Business Description

Description
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 1.56
Equity-to-Asset 0.54
Debt-to-Equity 0.43
Debt-to-EBITDA -0.18
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -8.3
Distress
Grey
Safe
Beneish M-Score -5.97
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.21
Quick Ratio 5.16
Cash Ratio 3.17
Days Sales Outstanding 1799.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -40.2
Shareholder Yield % -25.14

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -5082.18
Net Margin % -10337.16
ROE % -204.06
ROA % -128.47
ROIC % -108.4
ROC (Joel Greenblatt) % -820.34
ROCE % -158.47

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A
PS Ratio 6
EV-to-FCF -0.97
FCF Yield % -257.13